3Chopt Investment Partners LLC Has $400,000 Holdings in HCA Healthcare, Inc. $HCA

3Chopt Investment Partners LLC grew its stake in HCA Healthcare, Inc. (NYSE:HCA) by 9.2% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,043 shares of the company’s stock after buying an additional 88 shares during the quarter. 3Chopt Investment Partners LLC’s holdings in HCA Healthcare were worth $400,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Cheviot Value Management LLC acquired a new position in shares of HCA Healthcare in the first quarter valued at approximately $26,000. Saudi Central Bank acquired a new position in shares of HCA Healthcare in the first quarter valued at approximately $26,000. WPG Advisers LLC bought a new stake in shares of HCA Healthcare in the first quarter worth $27,000. Ameriflex Group Inc. bought a new stake in shares of HCA Healthcare in the second quarter worth $27,000. Finally, Chung Wu Investment Group LLC bought a new stake in shares of HCA Healthcare in the second quarter worth $27,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Buying and Selling

In related news, EVP Michael S. Cuffe sold 3,836 shares of the firm’s stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the transaction, the executive vice president directly owned 31,503 shares of the company’s stock, valued at approximately $13,194,716.52. This trade represents a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 1.30% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have recently commented on HCA shares. Barclays boosted their price objective on shares of HCA Healthcare from $390.00 to $445.00 and gave the stock an “overweight” rating in a research report on Thursday, September 18th. Truist Financial boosted their price objective on shares of HCA Healthcare from $390.00 to $415.00 and gave the stock a “buy” rating in a research report on Wednesday, July 16th. Royal Bank Of Canada dropped their price target on shares of HCA Healthcare from $404.00 to $401.00 and set an “outperform” rating on the stock in a research report on Monday, July 28th. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of HCA Healthcare in a research report on Wednesday. Finally, Morgan Stanley dropped their price target on shares of HCA Healthcare from $410.00 to $400.00 and set an “equal weight” rating on the stock in a research report on Monday, July 28th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $422.31.

HCA Healthcare Price Performance

Shares of HCA opened at $414.73 on Friday. The firm has a market capitalization of $97.04 billion, a PE ratio of 17.43, a PEG ratio of 1.32 and a beta of 1.40. The company’s 50-day moving average is $405.12 and its 200-day moving average is $375.58. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $439.01.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, beating the consensus estimate of $6.20 by $0.64. The company had revenue of $18.61 billion for the quarter, compared to analyst estimates of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The company’s revenue was up 6.4% on a year-over-year basis. During the same period in the prior year, the firm earned $5.50 earnings per share. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th were given a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend was Tuesday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is currently 12.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.